Bioequivalence tests on generic Tamiflu are still underway

Published: 2009-12-01 06:58:00
Updated: 2009-12-01 06:58:00
Local pharmaceutical companies have still embarked on their bioequivalence studies of their generic version of Tamiflu, health officials said recently.

Several companies including Kukje Pharm and Huons have received the green light to conduct a bioequivalence test to prove the therapeutic equ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.